AbbreviationsDAAs, direct-acting antivirals; DIHS, drug-induced hypersensitivity syndrome; DRESS, drug rash with eosinophilia and systemic symptoms; HCV, hepatitis C virus; CHC, chronic hepatites C; Peg-IFN, pegylated interferon; RBV, ribavirin; RVR, rapid virological response; SJS, Stevens--Johnson syndrome; SVR, sustained virological response; TPV, telaprevir; TEN, toxic epidermal necrolysis
Financial disclosureThe authors declare that they have nothing to disclose regarding funding from the industry or conflicts of interest with respect to the manuscript.
AbstractBackground: Telaprevir-based therapy for chronic hepatitis C patients is effective;
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.